Advertisement

Home / Business and Economy / Indian Stocks Open Lower as Pharma Sector Drags

Indian Stocks Open Lower as Pharma Sector Drags

Summary

  • Nifty 50 falls 44 points, Sensex drops 125 points
  • Bank Nifty opens 110 points lower
  • Pharma stocks like Dr Reddy's, Sun Pharma among top laggards
Indian Stocks Open Lower as Pharma Sector Drags

On October 30, 2025, Indian equity markets opened the trading session on a weaker note, with the benchmark Nifty 50 index falling 44 points or 0.17% to 26,010. The BSE Sensex also opened 125 points or 0.15% lower at 84,873.

The Bank Nifty, which tracks the performance of banking stocks, opened 110 points or 0.19% down at 58,275. However, the midcap stocks, as represented by the Nifty Midcap index, opened the day on a flat note, rising just 41 points or 0.07% to 60,190.

The key laggards in the Nifty 50 pack included pharmaceutical stocks like Dr Reddy's Laboratories, Sun Pharmaceutical, and HDFC Life Insurance. On the other hand, Larsen & Toubro, Wipro, Tata Motors, and Nestle India were among the top gainers in early trade.

Advertisement

Analysts noted that the market's recent momentum has eased off, with oscillators also appearing reluctant. However, they remain optimistic, stating that the presence of bullish continuation patterns encourages them to stay with the 26,186-26,250 view for the Nifty 50. They expect dips to 25,990 to find buying interest, with the downside marker placed near 25,886.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

Advertisement

The Indian stock market opened lower on October 30, 2025, with the Nifty 50 and Sensex falling due to weakness in pharmaceutical stocks.
In early trade, the top gainers in the Nifty 50 index included Larsen & Toubro, Wipro, Tata Motors, and Nestle India.
The Bank Nifty opened 110 points or 0.19% lower, while the Nifty Midcap index opened the day on a flat note, rising just 41 points or 0.07%.

Read more news on